JNJ NYSE
Johnson & Johnson
1W: -5.6%
1M: -6.9%
3M: -1.2%
YTD: +24.2%
1Y: +38.5%
3Y: +74.7%
5Y: +76.3%
$256.03
-2.63 (-1.02%)
Weekly Expected Move ±2.0%
$246
$251
$256
$261
$266
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
1 bullish
0 neutral
1 bearish
Articles (24h)
2
Hourly Sentiment (24h)
0.29
Neutral
12 bullish
9 neutral
4 bearish
Articles (7d)
25
Daily Sentiment (7 Days)
Articles (100)
Wall Street Is Bracing for the Fed's Next Move on Rates. These 3 Stocks Win Either Way.
The Stock Market Just Flashed a Warning Signal Seen Only Twice in 155 Years. Here Are 3 Stocks That Can Weather What History Says Comes Next.
Eli Lilly's Jaypirca gains additional indication for untreated leukemia, lymphoma
3 of the Best ETFs to Buy and Hold if a Recession Is Coming
Most and least shorted mid- to mega-cap healthcare stocks at the end of September
Can ABBV's New Parkinson's Pill Strengthen Its Neuroscience Franchise?
J&J's Innovative Medicine Segment in Q3: Key Growth Drivers to Watch
Medicare drug pricing model to affect only four firms after Trump’s MFN policy
Johnson & Johnson vs. Eli Lilly: Which Pharma Stock Can Make Your Portfolio Healthier in 2026?
Bristol-Myers Squibb vs. Johnson & Johnson: Comparing Quarterly Revenue Scale
ABBV Stock Rises 25% in 6 Months: Time to Buy, Hold or Sell?
History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade.
Is Wall Street Dead Wrong About Intuitive Surgical? Here's My Honest Answer.
If I Could Tell Every New Investor 1 Thing About Building Wealth in the Stock Market, It's This
FDA launches recruitment drive to add members to advisory panels
3 Reasons Johnson & Johnson Is Still a Buy With Its Stock Near a Record High
Pharmaceutical industry lobbying group names new CEO, Eric Cantor
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now
3 Healthcare Dividend Stocks Offering More Than Just Income
SCHD's Top Sector Bet Is Healthcare at 20.7%. I'm Not Sure What's More Surprising: What It Doesn't Hold, or What It Does.
Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Defensive Dividends: 3 Companies Investors Can Rely On
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
Pfizer, BioNTech, Moderna dealt blow in effort to dismiss mRNA patent lawsuits
Is AstraZeneca's Oncology Portfolio Positioned for Continued Growth?
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
FDA commissioner nominee Overton rebuffs questions about Trump medical claims
Pfizer or AbbVie: Which Big Pharma Stock Is the Better Pick?
Bear Markets May Feel Frightening, But Here's How You Can Come Out Ahead
Bristol Myers Squibb and Johnson & Johnson Both Face Challenges Ahead: Which Healthcare Stock Looks More Resilient Now?
Intuitive Surgical Stock Has Plunged 29% This Year. Is the Market Overreacting?
J&J says analysis demonstrates potential of Tecvayli-Darzalex combo for multiple myeloma
2 Stocks to Buy Hand Over Fist if a Stock Market Crash Is Coming
JNJ's Caplyta Shows Benefit in Bipolar 1 Related Mania Study
Johnson & Johnson May Offload Its Orthopedics Unit for $20 Billion -- and Investors Shouldn't Miss What That Could Signal
J&J sees positive late-stage data for Caplyta in reducing bipolar manic symptoms
The Investing Playbook for Retirees Who Can't Afford to Lose
Meet the Vanguard ETF That Increased Its SpaceX Holding by 39% in 1 Month and Shows No Signs of Slowing Down
Trump set to announce MFN pricing for Medicaid in all states
Can AstraZeneca's Broad Pipeline Offset Recent Setbacks?
J&J Up 18% in Three Months: Buy, Sell or Hold the Stock?
Trump administration is said to weigh allowing most pharma licensing deals with China
Nykredit A S Takes $235.82 Million Position in Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Shares Sold by Smith Chas P & Associates PA Cpas
Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue?
Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know
Looming biosimilar void risks $189B in lost U.S. healthcare savings: report
FDA Approves Label Expansion of BAYRY's Kidney Disease Drug Kerendia
Johnson & Johnson $JNJ Shares Bought by U S Wealth Group LLC.
Talon Private Wealth LLC Boosts Stock Position in Johnson & Johnson $JNJ
The Manufacturers Life Insurance Company Has $951.49 Million Stock Position in Johnson & Johnson $JNJ
National Pension Service Has $1.33 Billion Stock Position in Johnson & Johnson $JNJ
Van Hulzen Asset Management LLC Has $30.19 Million Stake in Johnson & Johnson $JNJ
Blue Edge Capital LLC Sells 3,464 Shares of Johnson & Johnson $JNJ
Core Capital Management & Research inc. Buys Shares of 4,002 Johnson & Johnson $JNJ
Archford Capital Strategies LLC Has $10.32 Million Stock Holdings in Johnson & Johnson $JNJ
How AbbVie's Neuroscience Portfolio Has Transformed Over the Years
Alvotech wins double upgrade at Barclays on upcoming FDA decision
Is AbbVie the Best Dividend King to Buy in September?
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
My Top 5 Favorite Stocks for an Uncertain Market
Johnson & Johnson $JNJ Shares Sold by HighTower Advisors LLC
Corient Private Wealth LP Has $577.64 Million Stock Holdings in Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Shares Purchased by IFP Advisors Inc
Waverly Advisors LLC Buys 42,556 Shares of Johnson & Johnson $JNJ
Empirical Finance LLC Has $21.64 Million Stake in Johnson & Johnson $JNJ
Tucker Asset Management LLC Purchases 3,178 Shares of Johnson & Johnson $JNJ
HORAN Wealth LLC Decreases Stock Position in Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Shares Purchased by Baird Financial Group Inc.
FDA launches pilot program that aims to speed the time to first-in-human drug trials
4 stocks to watch on Tuesday: JNJ, NYT, AAPL, and ETSY
3 Healthcare Stocks for 3 Stages of Life
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
California State Teachers Retirement System Raises Position in Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Shares Sold by Tobias Financial Advisors Inc.
J&J reports phase 2b data on less-frequent lung cancer treatment
Saudi Central Bank Increases Stock Position in Johnson & Johnson $JNJ
HB Wealth Management LLC Sells 2,520 Shares of Johnson & Johnson $JNJ
VIRGINIA RETIREMENT SYSTEMS ET Al Makes New $207.87 Million Investment in Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Shares Acquired by Kintra Wealth LLC
J&J/Contineum depression candidate fails in phase 2
Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio
Can Pfizer Overcome Its COVID and Patent Cliff Headwinds?
11,346 Shares in Johnson & Johnson $JNJ Purchased by NBH Bank
Maloon Powers Pitre Higgins & Dennehy LLC Purchases New Stake in Johnson & Johnson $JNJ
2,359 Shares in Johnson & Johnson $JNJ Purchased by Rose Capital Advisors LLC
William John Sempolinski Buys Shares of 2,131 Johnson & Johnson $JNJ
MW Advisory LLC Takes $1.13 Million Position in Johnson & Johnson $JNJ
Old Mission Investment Co LLC Acquires New Position in Johnson & Johnson $JNJ
Tenet Wealth Partners LLC Takes Position in Johnson & Johnson $JNJ
Noble Wealth Partners LLC Acquires New Stake in Johnson & Johnson $JNJ
Zacks Investment Ideas feature highlights: Johnson & Johnson, Coca-Cola and Exxon Mobil
Advisory Solutions Group LLC Invests $743,000 in Johnson & Johnson $JNJ
Azimuth Capital Investment Management LLC Sells 3,870 Shares of Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Shares Sold by Tudor Financial Inc.
Syon Capital LLC Acquires 2,817 Shares of Johnson & Johnson $JNJ
NEOS Investment Management LLC Buys 38,043 Shares of Johnson & Johnson $JNJ
TD Waterhouse Canada Inc. Buys 29,365 Shares of Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Shares Purchased by MOR Wealth Management LLC
Johnson & Johnson $JNJ Shares Bought by Concurrent Investment Advisors LLC